New Delhi, March 23 A study has identified a new biomarker for schizophrenia, which could also serve as a target for drugs to treat cognitive symptoms such as disorganized thinking or executive function.Schizophrenia is a mental health disorder characterized by an impaired ability to perceive...
biomarker
brain circuits
brain plasticity
cacna2d1
cerebrospinal fluid
clinical trials
cognitive symptoms
drug development
mental health disorders
neuroscience
peptidetherapy
protein
research study
schizophrenia
synapses